Jeremy Grantham Amneal Pharmaceuticals, Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.27 - $2.7 $29,337 - $62,370	23,100 New	23,100 $32,000
Q1 2022 May 13, 2022	BUY	$3.9 - $4.89 $476,190 - $597,069	122,100 Added 500.41%	146,500 $611,000
Q4 2021 Feb 11, 2022	BUY	$3.95 - $5.85 $96,380 - $142,740	24,400 New	24,400 $117,000
Q1 2021 May 13, 2021	SELL	$4.74 - $7.38 $733,278 - $1.14 Million	-154,700 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$3.95 - $5.42 $250,430 - $343,628	-63,400 Reduced 29.07%	154,700 $707,000
Q3 2020 Nov 13, 2020	BUY	$3.54 - $5.27 $772,074 - $1.15 Million	218,100 New	218,100 $846,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.